Vladimir Amani

3.9k total citations
30 papers, 1.8k citations indexed

About

Vladimir Amani is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Vladimir Amani has authored 30 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Genetics and 8 papers in Oncology. Recurrent topics in Vladimir Amani's work include Glioma Diagnosis and Treatment (16 papers), Single-cell and spatial transcriptomics (4 papers) and Neuroblastoma Research and Treatments (3 papers). Vladimir Amani is often cited by papers focused on Glioma Diagnosis and Treatment (16 papers), Single-cell and spatial transcriptomics (4 papers) and Neuroblastoma Research and Treatments (3 papers). Vladimir Amani collaborates with scholars based in United States, Netherlands and United Kingdom. Vladimir Amani's co-authors include Nicholas K. Foreman, Andrew M. Donson, Andrea M. Griesinger, Michael H. Handler, Diane K. Birks, Scott L. Pomeroy, Jean M. Mulcahy Levy, Lindsey M. Hoffman, Rajeev Vibhakar and Yoon-Jae Cho and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cell Reports.

In The Last Decade

Vladimir Amani

26 papers receiving 1.8k citations

Peers

Countries citing papers authored by Vladimir Amani

Since Specialization

Citations

This map shows the geographic impact of Vladimir Amani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vladimir Amani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vladimir Amani more than expected).

Fields of papers citing papers by Vladimir Amani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vladimir Amani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vladimir Amani. The network helps show where Vladimir Amani may publish in the future.

Co-authorship network of co-authors of Vladimir Amani

This figure shows the co-authorship network connecting the top 25 collaborators of Vladimir Amani. A scholar is included among the top collaborators of Vladimir Amani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vladimir Amani. Vladimir Amani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Loss of LDOC1 by chromatin compaction in mesenchymal tumor cells is required for PFA1 ependymoma growth 2025 ·Neuro-Oncology ·(unknown), (unknown), (unknown), Andrew M. Donson, Lays Martin Sobral, (unknown), (unknown), Vladimir Amani, Sujatha Venkataraman, (unknown), Jean M. Mulcahy Levy, Tzu Phang, Rajeev Vibhakar, Todd C. Hankinson, Michael Handler, Elvis Terci Valera, Nicholas K. Foreman, Andrea M. Griesinger	0
2	Genetic predictors of neurocognitive outcomes in survivors of pediatric brain tumors 2023 ·Journal of Neuro-Oncology ·(unknown), (unknown), Bridget Sanford, Andrew M. Donson, Kenneth L. Jones, Andrea M. Griesinger, Vladimir Amani, Nicholas K. Foreman, Arthur Liu, Michael H. Handler, Todd C. Hankinson, Sarah A. Milgrom, Jean M. Mulcahy Levy	1
3	Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas 2023 ·Acta Neuropathologica Communications ·Vladimir Amani, Kent Riemondy, Rui Fu, Andrea M. Griesinger, (unknown), (unknown), Ahmed Gilani, Molly Hemenway, Nicholas K. Foreman, Andrew M. Donson, (unknown)	6
4	Spatial transcriptomic analysis delineates epithelial and mesenchymal subpopulations and transition stages in childhood ependymoma 2022 ·Neuro-Oncology ·Rui Fu, Gregory Norris, (unknown), Andrea M. Griesinger, Kent Riemondy, Vladimir Amani, (unknown), (unknown), Todd C. Hankinson, Siddhartha S. Mitra, Timothy Ritzmann, (unknown), Nicholas K. Foreman, Andrew M. Donson	11
5	Single-Cell RNA Sequencing of Childhood Ependymoma Reveals Neoplastic Cell Subpopulations That Impact Molecular Classification and Etiology 2020 ·Cell Reports ·Austin E. Gillen, Kent Riemondy, Vladimir Amani, Andrea M. Griesinger, Ahmed Gilani, Sujatha Venkataraman, Krishna Madhavan, Eric Prince, Bridget Sanford, Todd C. Hankinson, Michael H. Handler, Rajeev Vibhakar, Ken L. Jones, Siddhartha S. Mitra, Jay R. Hesselberth, Nicholas K. Foreman, Andrew M. Donson	43
6	In vitro benchmarking of NF-κB inhibitors 2020 ·European Journal of Pharmacology ·(unknown), (unknown), Narendra Bharathy, (unknown), Noah Berlow, Nicholas K. Foreman, Andrew M. Donson, Vladimir Amani, William J. Zuercher, Charles Keller	6
7	Retrospective analysis of combination carboplatin and vinblastine for pediatric low-grade glioma 2020 ·Journal of Neuro-Oncology ·Anandani Nellan, Erin Wright, Kristen Campbell, Kurtis D. Davies, Andrew M. Donson, Vladimir Amani, (unknown), Molly Hemenway, Jennifer L. Raybin, Nicholas K. Foreman, Sarah Rush, Kathleen Dorris	14
8	Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood Ependymoma 2018 ·Molecular Cancer Therapeutics ·Andrew M. Donson, Vladimir Amani, (unknown), Andrea M. Griesinger, (unknown), Jean M. Mulcahy Levy, Lindsey M. Hoffman, Todd C. Hankinson, Michael H. Handler, Rajeev Vibhakar, Kathleen Dorris, Nicholas K. Foreman	23
9	Specific expression of PD‐L1 in RELA‐fusion supratentorial ependymoma: Implications for PD‐1‐targeted therapy 2018 ·Pediatric Blood & Cancer ·(unknown), Andrew M. Donson, Vladimir Amani, Daniel C. Moreira, Bridget Sanford, Lindsey M. Hoffman, Michael H. Handler, Jean M. Mulcahy Levy, Kenneth L. Jones, Anandani Nellan, Nicholas K. Foreman, Andrea M. Griesinger	41
10	Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors 2017 ·eLife ·Jean M. Mulcahy Levy, Shadi Zahedi, Andrea M. Griesinger, Andrew Morin, Kurtis D. Davies, Dara L. Aisner, (unknown), Brent E. Fitzwalter, Megan L. Goodall, Jacqueline Thorburn, Vladimir Amani, Andrew M. Donson, Diane K. Birks, David M. Mirsky, Todd C. Hankinson, Michael H. Handler, Adam L. Green, Rajeev Vibhakar, Nicholas K. Foreman, Andrew Thorburn	146
11	Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma 2016 ·BMC Cancer ·Vladimir Amani, Eric Prince, Irina Alimova, Ilango Balakrishnan, Diane K. Birks, Andrew M. Donson, Peter S. Harris, Jean M. Mulcahy Levy, Michael H. Handler, Nicholas K. Foreman, Sujatha Venkataraman, Rajeev Vibhakar	33
12	A WEE1 Inhibitor Analog of AZD1775 Maintains Synergy with Cisplatin and Demonstrates Reduced Single-Agent Cytotoxicity in Medulloblastoma Cells 2016 ·ACS Chemical Biology ·Christopher J. Matheson, Sujatha Venkataraman, Vladimir Amani, Peter S. Harris, Donald S. Backos, Andrew M. Donson, Michael F. Wempe, Nicholas K. Foreman, Rajeev Vibhakar, Philip Reigan	48
13	Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma 2015 ·Cancer Immunology Research ·Andrea M. Griesinger, (unknown), Andrew M. Donson, Jean M. Mulcahy Levy, Vladimir Amani, Diane K. Birks, Lindsey M. Hoffman, Steffanie L. Furtek, Philip Reigan, Michael H. Handler, Rajeev Vibhakar, Nicholas K. Foreman	56
14	Identification of targets for rational pharmacological therapy in childhood craniopharyngioma 2015 ·Acta Neuropathologica Communications ·Jacob M. Gump, Andrew M. Donson, Diane K. Birks, Vladimir Amani, Karun K. Rao, Andrea M. Griesinger, Bette K. Kleinschmidt‐DeMasters, James M. Johnston, Richard C. E. Anderson, Amy Rosenfeld, Michael H. Handler, Lia Gore, Nicholas K. Foreman, Todd C. Hankinson	83
15	Autophagy Inhibition Improves Chemosensitivity in BRAFV600E Brain Tumors 2014 ·Cancer Discovery ·Jean M. Mulcahy Levy, (unknown), Andrea M. Griesinger, Vladimir Amani, Andrew M. Donson, Diane K. Birks, Michael J. Morgan, David M. Mirsky, Michael H. Handler, Nicholas K. Foreman, Andrew Thorburn	188
16	Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma 2014 ·Oncotarget ·Sujatha Venkataraman, Irina Alimova, Ilango Balakrishnan, Peter S. Harris, Diane K. Birks, Andrea M. Griesinger, Vladimir Amani, (unknown), Marc Remke, Michael D. Taylor, Michael H. Handler, Nicholas K. Foreman, Rajeev Vibhakar	88
17	Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma 2013 ·Acta Neuropathologica ·Lindsey M. Hoffman, Andrew M. Donson, Ichiro Nakachi, Andrea M. Griesinger, Diane K. Birks, Vladimir Amani, Molly Hemenway, Arthur K. Liu, Michael Wang, Todd C. Hankinson, Michael H. Handler, Nicholas K. Foreman	57
18	Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma 2012 ·Acta Neuropathologica ·Shyamal Dilhan Weeraratne, Vladimir Amani, Natalia Teider, (unknown), Dominic Winter, Min Jeong Kye, Soma Sengupta, Tenley C. Archer, Marc Remke, Alfa Bai, Peter Warren, Stefan M. Pfister, Judith A. Steen, Scott L. Pomeroy, Yoon-Jae Cho	128
19	Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma 2010 ·Neuro-Oncology ·Natalia Teider, (unknown), Adrianne Neiss, Shyamal Dilhan Weeraratne, Vladimir Amani, Yifei Wang, Víctor E. Márquez, Yoon-Jae Cho, Scott L. Pomeroy	30
20	miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma 2010 ·Neuro-Oncology ·Shyamal Dilhan Weeraratne, Vladimir Amani, Adrianne Neiss, Natalia Teider, (unknown), Scott L. Pomeroy, Yoon Jae Cho	107

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact